Intradermal vaccination against influenza [3] (multiple letters)

New England Journal of Medicine

Volumn 352, Issue 10, 2005, Pages 1044-1046

  Weller, Thomas H ^a   Kilbourne, Edwin D ^b   Manian, Farrin A ^c   Belshe, Robert B ^d   Treanor, John ^e   Dubin, Gary ^f   Glenn, Gregory M ^g   Kenney, Richard T ^g  

^a New York Medical College ^*  (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c ST JOHN S MERCY MEDICAL CENTER   (United States)

^d SAINT LOUIS UNIVERSITY   (United States)

^e UNIVERSITY OF ROCHESTER   (United States)

^f GLAXOSMITHKLINE   (United States)

^g IOMAI Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; VIRUS ANTIBODY; INACTIVATED VACCINE; LIVE VACCINE;

ANTIBODY BLOOD LEVEL; CLINICAL TRIAL; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG SAFETY; HUMAN; IMMUNOGENICITY; INFLUENZA; INFLUENZA VACCINATION; LETTER; PRIORITY JOURNAL; VACCINE PRODUCTION; COMPARATIVE STUDY; INTRADERMAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; NOTE; SUBCUTANEOUS DRUG ADMINISTRATION; BLOOD; IMMUNOLOGY; INFLUENZA VIRUS A; INFLUENZA VIRUS B; DISEASE TRANSMISSION;

DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SUBCUTANEOUS; ANTIBODIES, VIRAL; INFLUENZA A VIRUS; INFLUENZA B VIRUS; VACCINES, ATTENUATED; VACCINES, INACTIVATED;

EID: 14744272984     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200503103521019     Document Type: Letter

References (0)